A Coronary Occlusion is when a blood vessel in the heart is blocked by a clot. The coronary arteries are the blood vessels in the heart that supply the rest of the body with oxygenated blood. The symptoms of a Coronary Occlusion include chest pain, shortness of breath, and fatigue. A Coronary Occlusion is caused by plaque buildup on the inner lining of the artery or by a temporary muscle spasm in the heart. Treatments for a Coronary Occlusion include medications to lower the heart rate, medications to relax the artery wall, and angioplasty to expand the artery. A Coronary Occlusion can lead to a heart attack which can have lasting effects on the body, but changes in diet and smoking habits can increase the outlook.
Coronary Occlusion Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Coronary Occlusion below!
For more information on how to use Laverne, please read the How to Guide.
We have 1739 products for the study of Coronary Occlusion that can be applied to Flow Cytometry, Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Coronary Occlusion is also known as Coronary Artery Occluded, Coronary Artery Occlusion, Coronary Occlusions, Occlusion Coronary, Occlusion Coronary Artery.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.